Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ballantyne

Showing results (1-10 of 1,153) with videos related to

Pageof 116
Sort By:
Journal of Cardiovascular Risk|December 29, 1998
Genetic and molecular markers for vascular disease. OverviewC M Ballantyne
The American Journal of Cardiology|November 18, 1998
Low-density lipoproteins and risk for coronary artery diseaseC M Ballantyne
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 27, 2000
Statins after cardiac transplantation: which statin, what dose, and how low should we go?C M Ballantyne
The American Journal of Cardiology|November 18, 2005
Rationale for targeting multiple lipid pathways for optimal cardiovascular risk reductionChristie M Ballantyne
A Report of the ... National Forum on Hospital and Health Affairs. National Forum on Hospital and Health Affairs|December 9, 1992
Initiating the network as a joint ventureR M Ballantyne
Clinical Cardiology|August 15, 2001
Newer risk markers and surrogate endpoints in atherosclerosis managementC M Ballantyne
Postgraduate Medicine|August 12, 2009
Strategies for optimizing lipid managementChristie M Ballantyne
The American Journal of Medicine|July 31, 1998
Current thinking in lipid loweringC M Ballantyne
Critical Pathways in Cardiology|August 2, 2007
Increasing prevalence of obesity and clustered cardiometabolic risk: can treatment of the underlying cause reverse the trends?Christie M Ballantyne
Trustee : the Journal for Hospital Governing Boards|October 1, 1993
The real meaning of partnershipsR M Ballantyne
Pageof 116

Showing results (1-10 of 1,153) with videos related to

Sort By:
Pageof 116
Journal of Cardiovascular Risk|December 29, 1998
Genetic and molecular markers for vascular disease. OverviewC M Ballantyne
The American Journal of Cardiology|November 18, 1998
Low-density lipoproteins and risk for coronary artery diseaseC M Ballantyne
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 27, 2000
Statins after cardiac transplantation: which statin, what dose, and how low should we go?C M Ballantyne
The American Journal of Cardiology|November 18, 2005
Rationale for targeting multiple lipid pathways for optimal cardiovascular risk reductionChristie M Ballantyne
A Report of the ... National Forum on Hospital and Health Affairs. National Forum on Hospital and Health Affairs|December 9, 1992
Initiating the network as a joint ventureR M Ballantyne
Clinical Cardiology|August 15, 2001
Newer risk markers and surrogate endpoints in atherosclerosis managementC M Ballantyne
Postgraduate Medicine|August 12, 2009
Strategies for optimizing lipid managementChristie M Ballantyne
The American Journal of Medicine|July 31, 1998
Current thinking in lipid loweringC M Ballantyne
Critical Pathways in Cardiology|August 2, 2007
Increasing prevalence of obesity and clustered cardiometabolic risk: can treatment of the underlying cause reverse the trends?Christie M Ballantyne
Trustee : the Journal for Hospital Governing Boards|October 1, 1993
The real meaning of partnershipsR M Ballantyne
Pageof 116